- Home
- SIBN vs ALMS Comparison
SIBN vs ALMS Comparison
Compare SIBN & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIBN
- ALMS
- Stock Information
- Founded
- SIBN 2008
- ALMS 2021
- Country
- SIBN United States
- ALMS United States
- Employees
- SIBN N/A
- ALMS N/A
- Industry
- SIBN Medical/Dental Instruments
- ALMS
- Sector
- SIBN Health Care
- ALMS
- Exchange
- SIBN Nasdaq
- ALMS NYSE
- Market Cap
- SIBN 547.3M
- ALMS 469.0M
- IPO Year
- SIBN 2018
- ALMS 2024
- Fundamental
- Price
- SIBN $17.84
- ALMS $5.17
- Analyst Decision
- SIBN Strong Buy
- ALMS Strong Buy
- Analyst Count
- SIBN 6
- ALMS 7
- Target Price
- SIBN $23.00
- ALMS $28.83
- AVG Volume (30 Days)
- SIBN 326.8K
- ALMS 280.9K
- Earning Date
- SIBN 02-24-2025
- ALMS 03-07-2025
- Dividend Yield
- SIBN N/A
- ALMS N/A
- EPS Growth
- SIBN N/A
- ALMS N/A
- EPS
- SIBN N/A
- ALMS N/A
- Revenue
- SIBN $157,035,000.00
- ALMS N/A
- Revenue This Year
- SIBN $21.89
- ALMS N/A
- Revenue Next Year
- SIBN $16.65
- ALMS N/A
- P/E Ratio
- SIBN N/A
- ALMS N/A
- Revenue Growth
- SIBN 18.98
- ALMS N/A
- 52 Week Low
- SIBN $11.70
- ALMS $4.74
- 52 Week High
- SIBN $20.60
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- SIBN 61.08
- ALMS N/A
- Support Level
- SIBN $17.30
- ALMS N/A
- Resistance Level
- SIBN $18.45
- ALMS N/A
- Average True Range (ATR)
- SIBN 0.82
- ALMS 0.00
- MACD
- SIBN 0.00
- ALMS 0.00
- Stochastic Oscillator
- SIBN 74.58
- ALMS 0.00
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.